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ABSTRACT
Introduction: The most effective way to prevent 
thalassemia is to screen for the disease at the 
population level and then to evaluate the molecu-
larity of individuals. Considering the importance 
of minor β-thalassemia and its high prevalence in 
societies. Aim: to investigate the incidence of minor 
β-thalassemia among Individuals participated in 
Premarital Screening Program in Ardabil province: 
North-west of Iran. Methods: This descriptive cross-
sectional study was conducted on 39620 individu-
als participated in the national screening program 
for Minor β-Thalassemia. Of them 1925 cases had 
mean corpuscular volume (MCV) < 80 in one person 
or couple which referred to HbA2 concentration 
check. Results: Of all 1925 cases, 95 cases (4.93%) 
had HbA2>3.5 and defined as Minor β-Thalassemia. 
The total incidence of minor β-thalassemia among 
all participated people was 2.4%. Of thalassemia 
cases 48.4% were women and 51.6% were men. 
Of all β-thalassemia cases, 49.5% live in Ardabil 
city and rest of them live in other cities. Conclu-
sion: Results showed that the prevalence of minor 
β-thalassemia in Ardabil province was lower than 
country average rate and a study should be done in 
future for exact estimation of the disease.
Keywords: Minor β-Thalassemia, Screening, MCH, 
MCV, Ardabil.
1. INTRODUCTION
Thalassemia is one of the most common ge-
netic diseases in Iran and due to it , the patient’s 
blood loses a large number of red blood cells and 
unable to carry oxygen. Hemoglobin consists 
of two different chains called alpha and beta. 
If the body doesn’t have the ability to produce 
enough protein of any kind, the blood cells are 
not completely formed and don’t have the abil-
ity to transfer sufficient oxygen and the result 
is an anemia that begins in childhood and lasts 
up to the end of life. 
Thalassemia is found in people of Mediter-
ranean such as Greece and Italy, Iran, Africa, 
South Asia and South China (1-3). Disruption of 
the alpha chain genes causes alpha thalassemia. 
The other chain of hemoglobin is the beta chain 
and disruption of the beta gene causes major 
beta-thalassemia and because there are only 
two beta genes in comparison to the alpha gene, 
the probability of defective both versions is high 
when the parents are carriers of thalassemia. 
For this reason the prevalence of beta thal-
assemia is much higher than that of alpha (4-
6). In beta-thalassemia if a gene is defective 
it is known as minor thalassemia and there is 
no particular problem in these people. If both 
beta genes are defective, they cause a danger-
ous thalassemia type called major thalassemia. 
Major thalassemia occurs only when the parents 
of the affected person have both minor thalas-
semia (5-8). 
There are three types of beta thalassemia 
depending on their effects they are classified 
in the body from mild to severe. a) Minor Thal-
assemia: in this case protein deficiency is not 
sufficient to disrupt the hemoglobin function. 
A person with this disease carries a genetic 
property of thalassemia. This person will not 
experience a problem other than a slight anemia 
in some cases. As with mild alpha thalassemia, 
physicians treat red blood cells of a person with 
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beta minor thalassemia as a sign of iron deficiency anemia 
with inappropriate iron supplementation. b) Intermediate 
thalassemia, In this case the deficiency of beta protein in 
the hemoglobin is so high that it leads to relatively severe 
anemia and significant impairment in the health of the 
individual such as bone malformations and enlargement 
of the spleen. There is a wide range of symptoms at this 
stage (3-5). A slight difference between the symptoms of 
intermediate thalassemia and the severe form (major thal-
assemia) or large thalassemia may be confusing . Because 
of the patient’s dependence on blood transfusion, the per-
son is placed in the major thalassemia group. Patients with 
intermediate thalassemia require a blood transfusion to 
improve their quality of life and not to save. c) Major thal-
assemia or major thalassemia anemia (Cooley’s Anemia), 
this stage is the most severe form of beta thalassemia, 
which results in a severe deficiency of beta protein in he-
moglobin, which leads to an anemia that is life-threatening 
and needs a lot of regular blood transfusions and medical 
care. Repeated blood transfusions in life duration lead to 
excessive iron agglomeration that they should be treated 
with prescribing chelator agents to help prevent death and 
organ failure. Thalassemia is detected by examining the 
level of hemoglobin in humans . The number of red blood 
cells and hemoglobin in people with thalassemia is lower 
than normal rate (12-14). 
For the primary diagnosis of beta and alpha thalassemia 
and iron deficiency anemia electrophores hemoglobin and 
CBC blood tests are used. In minor β-thalassemia, the MCV 
below 80, MCH below 27 and HbA2 greater than 3.5. If a 
person had all of the above conditions, would be consid-
ered a definite carriers of β-thalassemia and if intend to 
marry a person with β-thalassemia, he must has a genetic 
test. In alpha thalassemia, the indexes will be similar to 
beta only with the difference that the HbA2 level below 
3.5. In iron deficiency anemia the indices will be similar 
to alpha minor thalasemia with this different that the to-
tal amount of hemoglobin displayed with the Hb index is 
lower than 10. Also in these people, the amount of ferritin 
is at minimum rate (15-18). There are over 200 different 
mutations for β-thalassemia and the result is a reduction 
or loss of globin , although rare. About 20 common alleles 
make up 80% of known thalasemics around the world, 
3% of the world’s population carry genes associated with 
β-thalassemia. In Southeast Asia,5-10% of people carry 
α-thalassemia genes. In the United States, nearly 2,000 
people have β-thalassemia. Currently the most effective 
way to prevent thalassemia is to screening disease at the 
population level and then to evaluate the molecularity of 
the individual which in screening program known as thal-
assemia carriers. The thalassemia prevention program in 
Iran is based upon premarital screening of β-thalassemic 
couples (carriers) in order to encourage them to participate 
in counseling and perform prenatal diagnosis (PND) (19).
2. AIM
Therefore, the aim of this study was to identify the in-
cidence of minor β-thalassemia among Individuals partici-
pated in Premarital Screening Program in Ardabil province: 
North-west of Iran.
3. METHODS
Study design
In this cross-sectional study, 3962 individuals par-
ticipated in the national screening program for minor 
β-thalassemia and of them, 1925 cases (48.6%) had MCV<80. 
All of cases with MCV<80 were checked for HbA2 concentra-
tions. A checklist including MCV, MCH and HbA2 indices 
and residence of place, sex was completed for all patients 
and the prevalence of β- thalassemia was estimated based 
on the results of the HbA2 concentration.
Statistical Analysis
Collected data were analyzed using statistical methods 
in SPSS version 19. This research was approved by ethical 
committee of Ardabil university of medical sciences with 
the code IR.ARUMS.REC.1396.236.
4. RESULTS
In 1925 individuals with MCV<80 the, HbA2 concentra-
tions were measured that of them 95 case (4.94%) had minor 
β-thalassemia. Of all cases with minor β-thalassemia, 48.4% 
were women and 51.6% were men. Also, the total incidence 
of minor β-thalassemia in all participated was 2.4%.
The average HbA2 was 4.6±0.4 in men and 4.2±0.5 in 
women and the difference was significant.
5. DISCUSSION
In the present study, the total incidence of minor 
β-thalassemia among all participated cases was 2.4% in 
Ardabil province that this rate in Ardabil city was 1.63% and 
in other cities was 4.46% . The mean of HbA2 was 4.6±0.4 in 
men and 4.2±0.5 in women and the difference was signifi-
cant. (p=0.001) In the study of Afrouz et al, the prevalence 
of alpha-thalassemia with 78.4% , non-alpha beta with 9% 
and beta-thalasemia with 8.1% had the highest rate orderly. 
The average of MCV was significantly higher in patients 
with alpha-thalassemia than patients with β-thalassemia. 
There was a significant correlation between MCV and MCH 
among all patients (r=0.83, p=0.001) (20). In the study of 
Hayatbakhsh et al in Kerman, 5.7% of individuals had minor 
beta-thalasemia that of them 51.6% were men and rest of 
them were women and the difference wasn’t significant and 
Residence place Number of Referred Individuals 
Incidence (of total, 
%) HbA2 measured (n)
Number of thalassemia 
cases
Prevalence rate 
(based HbA2, %)
Ardabil city 2886 1.63 1402 47 3.35
Other cities 1076 4.46 523 48 9.2
Total 3962 2.4 1925 95 4.94
Table 1. The incidence rate of minor β-thalassemia in Ardabil province
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this rate was upper than our study results (21). In the study 
of Chehkandi et al, of all individuals, 7.1% had microcytosis 
that after receiving iron as orally, 41.2% of them weren’t 
corrected which 35.7% had HbA2>3.7% and called carriers 
of β-thalassemia (22).
In the study of Madmouli et al in 2017, 13.2% of individu-
als had intermediate and 86.8% major thalasemia . There 
was a significant relationship between thalassemia type 
and diagnosis age of thalassemia (P = 0.001) . There was a 
significant positive correlation between age and distance 
between transfusions (23).
In a study by Nabipoor et al, the overall incidence of 
β-thalassemia was 2.6% which was similar to our study 
results (2.4%) (24).
Some studies in other places of country are similar to 
results of the present study (25-27) but in some studies 
the prevalence of minor β-thalassemia was greater than 
our study results (20, 28). Also in the study of Rahmani et 
al, the prevalence of minor β-thalassemia was significantly 
lower than our study rate (29).
6. CONCLUSION
Results showed that the total incidence of minor 
β-thalassemia in the studied years based HbA2 concen-
tration in Ardabil province was 2.4%, in Ardabil city was 
1.63% and other cities was 4.46% which was lower than 
other studies within country. It is suggested that a study 
be conducted on a larger dimension among school age stu-
dents in the future.
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